News
-
Sponsors’ update
Wednesday | Apr 17 2024THE TGA recently unveiled the updated Assessed Listed Medicines Evidence Guidelines to make the application process for pharmaceutical product sponsors easier.
-
UK body backs chronic migraine drug
Wednesday | Apr 17 2024THE National Institute for Health and Care Excellence, UK, recently endorsed atogepant, a new oral treatment for preventing chronic and episodic migraines, potentially benefiting up to 170,000 NHS patients.
-
Dispensary Corner 17 Apr 24
Wednesday | Apr 17 2024IN A world where anger management is the name of the game, researchers have unveiled a quirky strategy: tossing out your troubles, literally.
-
Peters wins top fellowship
Tuesday | Apr 16 2024THE 2024 Asthma and Airways Career Development Fellowship was awarded yesterday to food allergy researcher A/Prof Rachel Peters (pictured).
-
Botanix listed on All Ords
Tuesday | Apr 16 2024DERMATOLOGY company Botanix Pharmaceuticals Limited has been officially included yesterday in the Australian Securities Exchange (ASX) All Ordinaries Index (All Ords).
-
3D films target tumours
Tuesday | Apr 16 2024RESEARCHERS at the University of South Australia have developed a new method for treating liver cancer, using 3D printed films that deliver chemotherapy drugs directly to the site of the tumour.
-
Save and fly soon
Tuesday | Apr 16 2024POINTRS is offering pharmacy customers ways to save on travel by using cash, credit card and loyalty points.
-
Committees’ Chairs
Tuesday | Apr 16 2024TWO of the country's peak medical bodies have made appointments.
-
World Health Summit
Tuesday | Apr 16 2024THE World Health Summit Regional Meeting 2024 will convene in Melbourne, from 22-24 Apr, marking the event's debut in the country.
-
PSA’s prescribing position statement out
Tuesday | Apr 16 2024THE Pharmaceutical Society of Australia (PSA) has issued a new position statement advocating for expanded pharmacist prescribing authority, asserting the necessity for community pharmacists to operate at the full extent of their capabilities.